The 11th webinar in the "Moving for Hepatitis Discovery to Elimination" series is hosted by National Institute of Diabetes and Digestive Diseases (NIDDK).

The Hepatitis B Research Network (HBRN) was a multicenter network established by NIDDK to investigate the etiology and progression of hepatitis B (HBV) and to test the safety and efficacy of current therapies. Join this webinar to learn of highlights from the research conducted by the Network.

Agenda

Welcome and Introductions | Jay Hoofnagle and John Ward

Presenters:

     Anna Lok, University of Michigan | Chronic hepatitis B in the US: clinical features, natural history and outcomes

     Will Lee, University of Texas Southwestern | Acute hepatitis B: clinical features of 60 US Cases 

     Norah Terrault, University of Southern California | Treatment Strategies to Increase HBsAg Loss: Outcomes from the HBRN Immune Active Trial

Round table discussion: 

• Patrizia Farci, NIAID/NIH
• Paul Skip Hayashi, FDA
• Brian McMahon, US CDC